176 related articles for article (PubMed ID: 349501)
1. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
Boukari M; Rottembourg J; Jaudon MC; Clavel JP; Legrain M; Galli A
Nouv Presse Med; 1978 Jan; 7(2):85-8. PubMed ID: 349501
[TBL] [Abstract][Full Text] [Related]
2. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency.
Zumkley H; Bertram HP; Lison A; Knoll O; Losse H
Clin Nephrol; 1979 Jul; 12(1):18-21. PubMed ID: 477052
[TBL] [Abstract][Full Text] [Related]
3. [Kinetics of aluminum absorption and serum concentration in chronic renal insufficiency].
Sárszegi Z; Jobst K; Nagy J
Orv Hetil; 2000 Aug; 141(35):1915-7. PubMed ID: 11019592
[TBL] [Abstract][Full Text] [Related]
4. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].
Buge A; Poisson M; Masson S; Bleibel JM; Lafforgue B; Raymond P; Jaudon MC
Nouv Presse Med; 1978 Jun; 7(23):2053-9. PubMed ID: 673773
[TBL] [Abstract][Full Text] [Related]
5. [Determination of the plasma aluminum concentration of hemodialysis patients].
Kuleva V; Petrov I; Antonov S; Kiriakov Z
Vutr Boles; 1984; 23(2):51-5. PubMed ID: 6741112
[TBL] [Abstract][Full Text] [Related]
6. [Aluminum-balance during haemodialysis (author's transl)].
Graf H; Stummvoll HK; Kovarik J; Meisinger V; Wolf A; Pinggera WF
Wien Klin Wochenschr; 1980; 92(11):391-4. PubMed ID: 7424016
[TBL] [Abstract][Full Text] [Related]
7. Level-dependent inhibitory effect of hyperaluminaemia on parathyroid hormone secretion in patients with end-stage renal failure.
Fernández E; Amoedo ML; Montoliu J
Eur J Med; 1992 Dec; 1(8):482-4. PubMed ID: 1341207
[TBL] [Abstract][Full Text] [Related]
8. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
[TBL] [Abstract][Full Text] [Related]
9. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
[TBL] [Abstract][Full Text] [Related]
10. [Reversible dialytic encephalopathy after interruption of aluminium intake. 6 cases (author's transl)].
Buge A; Poisson M; Masson S; Bleibel JM; Mashaly R; Jaudon MC; Lafforgue B; Lebkiri B; Raymond P
Nouv Presse Med; 1979 Sep; 8(34):2729-33. PubMed ID: 493078
[TBL] [Abstract][Full Text] [Related]
11. [Progressive dialytic encephalopathy. Role of the aluminium and neurological study. One case (author's transl)].
Buge A; Escourolle R; Poisson M; Gray F; Bleibel JM; Jaudon MC
Nouv Presse Med; 1979 Mar; 8(13):1071-4. PubMed ID: 461135
[TBL] [Abstract][Full Text] [Related]
12. [Aluminum absorption in the presence of normal kidney function: the effect of the pH].
Olaizola Ottonello I; Serrano Arias M; Vizoso Piñeiro F; Rodrigo Saez L; García Morán M; Cannata Andía JB
Rev Clin Esp; 1991 May; 188(9):442-5. PubMed ID: 1896590
[TBL] [Abstract][Full Text] [Related]
13. Serum aluminium measurement by DC plasma emission spectrometry.
Roberts NB; Williams P
Ann Clin Biochem; 1988 Mar; 25 ( Pt 2)():169-75. PubMed ID: 3382147
[TBL] [Abstract][Full Text] [Related]
14. [The natural history of dialysis encephalopathy (author's transl)].
Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
[TBL] [Abstract][Full Text] [Related]
15. [Aluminum poisoning caused by the phosphate binder in a non-dialysed child with chronic renal insufficiency].
Feldmann B; Färber D; Pontz BF
Radiologe; 1992 Jul; 32(7):327-32. PubMed ID: 1509030
[TBL] [Abstract][Full Text] [Related]
16. Plasma aluminium levels in patients on maintenance haemodialysis fall when oral aluminium hydroxide is withdrawn.
Wallace MR; Pybus J
N Z Med J; 1983 Oct; 96(742):793-5. PubMed ID: 6578451
[TBL] [Abstract][Full Text] [Related]
17. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
[No Abstract] [Full Text] [Related]
18. Aluminium load in patients with analgesic nephropathy.
Schwarz A; Kraft D; Keller F; Gawlik D; Offermann G
Miner Electrolyte Metab; 1987; 13(3):141-6. PubMed ID: 3627045
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. In end-stage renal failure, does infection lead to elevated plasma aluminium and neurotoxicity? Implications for monitoring.
Fenwick S; Roberts EA; Mahesh BS; Roberts NB
Ann Clin Biochem; 2005 Mar; 42(Pt 2):149-52. PubMed ID: 15829127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
